| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.35e-06 | 18 | 133 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | DOCK11 DOCK9 RASGEF1A DENND4C RAB3GAP1 SBF1 DENND5A ARHGEF3 HERC2 | 2.49e-05 | 231 | 133 | 9 | GO:0005085 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.40e-05 | 28 | 133 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC4 ABCA4 DNAH10 MYO1E DNAH2 UBA2 MCM5 DNAH7 ATP6V0D1 MDN1 DNAH17 SHPRH ABCB11 ACIN1 | 6.17e-05 | 614 | 133 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.05e-04 | 37 | 133 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | phosphatidate cytidylyltransferase activity | 1.32e-04 | 3 | 133 | 2 | GO:0004605 | |
| GeneOntologyMolecularFunction | odorant binding | 2.09e-04 | 127 | 133 | 6 | GO:0005549 | |
| GeneOntologyMolecularFunction | SUMO binding | 2.59e-04 | 19 | 133 | 3 | GO:0032183 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 2.62e-04 | 4 | 133 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | RIG-I binding | 2.62e-04 | 4 | 133 | 2 | GO:0039552 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 2.62e-04 | 4 | 133 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 2.62e-04 | 4 | 133 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 2.62e-04 | 4 | 133 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 2.62e-04 | 4 | 133 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR2B2 OR6K2 OR5B17 OR4E1 OR8K3 OR10R2 OR51F1 OR52R1 OR10J4 OR56B4 | 6.30e-04 | 431 | 133 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.51e-04 | 441 | 133 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2B2 OR6K2 OR5B17 OR4E1 OR8K3 OR10R2 LPAR1 OR51F1 OR52R1 NPY4R2 CELSR1 NPY4R ADGRE4P OR10J4 OR56B4 | 8.15e-04 | 884 | 133 | 15 | GO:0004930 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.17e-03 | 118 | 133 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | alcohol transmembrane transporter activity | 1.20e-03 | 8 | 133 | 2 | GO:0015665 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.23e-03 | 70 | 133 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.23e-03 | 70 | 133 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 1.54e-03 | 9 | 133 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | cytidylyltransferase activity | 1.91e-03 | 10 | 133 | 2 | GO:0070567 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 2.33e-03 | 11 | 133 | 2 | GO:0004983 | |
| GeneOntologyBiologicalProcess | detection of stimulus | CDS1 ABCA4 OR2B2 OR6K2 CDS2 OR5B17 OR4E1 PCARE OR8K3 OR10R2 OR51F1 OR52R1 GUCY2F PKD1 OR10J4 OR56B4 | 2.06e-05 | 722 | 135 | 16 | GO:0051606 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | ABCC4 DOCK11 DNAH2 CCDC57 ARMC2 DNAH7 TENM2 LPAR1 CDK10 FSIP2 ATP6V0D1 DNAH17 TMEM231 CLRN1 AGRN | 3.38e-05 | 670 | 135 | 15 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | ABCC4 DOCK11 DNAH2 CCDC57 ARMC2 DNAH7 TENM2 LPAR1 CDK10 FSIP2 ATP6V0D1 DNAH17 TMEM231 CLRN1 AGRN | 4.35e-05 | 685 | 135 | 15 | GO:0030031 |
| GeneOntologyBiologicalProcess | organelle assembly | CDS1 ABCC4 RELN CENPT CDS2 DNAH2 ATG14 CCDC57 ARMC2 DNAH7 LPAR1 CDK10 FSIP2 RAB3GAP1 ATP6V0D1 MDN1 DNAH17 TMEM231 GOLGA2 AP3S2 | 5.12e-05 | 1138 | 135 | 20 | GO:0070925 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 7.41e-05 | 210 | 135 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 8.73e-05 | 215 | 135 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 8.73e-05 | 215 | 135 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | detection of light stimulus | 1.51e-04 | 77 | 135 | 5 | GO:0009583 | |
| GeneOntologyBiologicalProcess | cilium assembly | ABCC4 DNAH2 CCDC57 ARMC2 DNAH7 LPAR1 CDK10 FSIP2 ATP6V0D1 DNAH17 TMEM231 | 1.66e-04 | 444 | 135 | 11 | GO:0060271 |
| GeneOntologyBiologicalProcess | microtubule-based process | FLOT2 DNAH10 ADAM7 DNAH2 STMND1 CCDC57 ARMC2 DNAH7 FSIP2 DST DNAH17 SLC9B2 PKD1 CCDC68 AGRN GOLGA2 TUBAL3 AP3S2 | 1.88e-04 | 1058 | 135 | 18 | GO:0007017 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.89e-05 | 25 | 135 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | inner dynein arm | 3.06e-05 | 10 | 135 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | cilium | ABCC4 ABCA4 DNAH10 DNAH2 PCARE ATG14 DNAH7 CDK10 FSIP2 SHANK2 GUCY2F DNAH17 SLC9B2 PKD1 CCDC68 TMEM231 | 2.27e-04 | 898 | 135 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | dynein complex | 4.10e-04 | 54 | 135 | 4 | GO:0030286 | |
| HumanPheno | Coiled sperm flagella | 4.34e-07 | 32 | 49 | 6 | HP:0032560 | |
| HumanPheno | Abnormal sperm tail morphology | 2.69e-06 | 43 | 49 | 6 | HP:0012868 | |
| HumanPheno | Reduced sperm motility | 3.36e-06 | 69 | 49 | 7 | HP:0012207 | |
| HumanPheno | Absent sperm flagella | 5.56e-06 | 28 | 49 | 5 | HP:0032558 | |
| HumanPheno | Short sperm flagella | 1.30e-05 | 33 | 49 | 5 | HP:0032559 | |
| HumanPheno | Abnormal sperm morphology | 3.39e-05 | 66 | 49 | 6 | HP:0012864 | |
| HumanPheno | Abnormal germ cell morphology | 3.70e-05 | 67 | 49 | 6 | HP:0012862 | |
| HumanPheno | Abnormal male germ cell morphology | 3.70e-05 | 67 | 49 | 6 | HP:0012863 | |
| HumanPheno | Abnormal sperm motility | 9.76e-05 | 115 | 49 | 7 | HP:0012206 | |
| HumanPheno | Abnormal sperm physiology | 9.76e-05 | 115 | 49 | 7 | HP:0034809 | |
| Domain | PC_trans | 4.66e-05 | 2 | 128 | 2 | IPR000374 | |
| Domain | PC_Trfase_euk | 4.66e-05 | 2 | 128 | 2 | IPR016720 | |
| Domain | Sec15 | 4.66e-05 | 2 | 128 | 2 | PF04091 | |
| Domain | CDS | 4.66e-05 | 2 | 128 | 2 | PS01315 | |
| Domain | NPY4_rcpt | 4.66e-05 | 2 | 128 | 2 | IPR001933 | |
| Domain | EXOC6/Sec15 | 4.66e-05 | 2 | 128 | 2 | IPR007225 | |
| Domain | AAA | 6.08e-05 | 144 | 128 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 6.08e-05 | 144 | 128 | 7 | IPR003593 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.08e-04 | 14 | 128 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.08e-04 | 14 | 128 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.08e-04 | 14 | 128 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.08e-04 | 14 | 128 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.08e-04 | 14 | 128 | 3 | IPR011704 | |
| Domain | MT | 1.08e-04 | 14 | 128 | 3 | PF12777 | |
| Domain | AAA_8 | 1.08e-04 | 14 | 128 | 3 | PF12780 | |
| Domain | AAA_5 | 1.08e-04 | 14 | 128 | 3 | PF07728 | |
| Domain | DHC_fam | 1.35e-04 | 15 | 128 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.35e-04 | 15 | 128 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.35e-04 | 15 | 128 | 3 | IPR004273 | |
| Domain | PAH | 1.39e-04 | 3 | 128 | 2 | IPR003822 | |
| Domain | - | 1.39e-04 | 3 | 128 | 2 | 1.20.1160.11 | |
| Domain | PAH | 1.39e-04 | 3 | 128 | 2 | PS51477 | |
| Domain | PAH | 1.39e-04 | 3 | 128 | 2 | PF02671 | |
| Domain | DENN | 1.65e-04 | 16 | 128 | 3 | SM00799 | |
| Domain | DENN | 1.65e-04 | 16 | 128 | 3 | PF02141 | |
| Domain | dDENN | 1.65e-04 | 16 | 128 | 3 | PF03455 | |
| Domain | UDENN | 1.65e-04 | 16 | 128 | 3 | PS50946 | |
| Domain | DDENN | 1.65e-04 | 16 | 128 | 3 | PS50947 | |
| Domain | dDENN | 1.65e-04 | 16 | 128 | 3 | SM00801 | |
| Domain | dDENN_dom | 1.65e-04 | 16 | 128 | 3 | IPR005112 | |
| Domain | uDENN_dom | 1.65e-04 | 16 | 128 | 3 | IPR005113 | |
| Domain | DENN | 1.65e-04 | 16 | 128 | 3 | PS50211 | |
| Domain | DENN_dom | 1.65e-04 | 16 | 128 | 3 | IPR001194 | |
| Domain | DUF3398 | 6.87e-04 | 6 | 128 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 6.87e-04 | 6 | 128 | 2 | IPR021816 | |
| Domain | DHC_N1 | 1.27e-03 | 8 | 128 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.27e-03 | 8 | 128 | 2 | IPR013594 | |
| Domain | GPS | 1.61e-03 | 34 | 128 | 3 | SM00303 | |
| Domain | Biotin_lipoyl | 1.63e-03 | 9 | 128 | 2 | PF00364 | |
| Domain | NPY_rcpt | 1.63e-03 | 9 | 128 | 2 | IPR000611 | |
| Domain | GPS | 1.75e-03 | 35 | 128 | 3 | PF01825 | |
| Domain | GPS | 1.90e-03 | 36 | 128 | 3 | PS50221 | |
| Domain | BIOTINYL_LIPOYL | 2.02e-03 | 10 | 128 | 2 | PS50968 | |
| Domain | Biotin_lipoyl | 2.02e-03 | 10 | 128 | 2 | IPR000089 | |
| Domain | GPS | 2.06e-03 | 37 | 128 | 3 | IPR000203 | |
| Domain | DHR-1_domain | 2.46e-03 | 11 | 128 | 2 | IPR027007 | |
| Domain | DHR_2 | 2.46e-03 | 11 | 128 | 2 | PS51651 | |
| Domain | DHR_1 | 2.46e-03 | 11 | 128 | 2 | PS51650 | |
| Domain | DHR-2 | 2.46e-03 | 11 | 128 | 2 | PF06920 | |
| Domain | DOCK | 2.46e-03 | 11 | 128 | 2 | IPR026791 | |
| Domain | DOCK_C | 2.46e-03 | 11 | 128 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 2.46e-03 | 11 | 128 | 2 | PF14429 | |
| Domain | DHR-2 | 2.46e-03 | 11 | 128 | 2 | IPR027357 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 3.69e-05 | 27 | 100 | 4 | M47755 | |
| Pubmed | GPR89B EXOC6 ARMT1 TRAPPC11 FLOT2 ABCA4 ACACB CDS2 DNAH2 ATG14 DNAH7 YEATS2 RAB3GAP1 SALL1 MDN1 | 3.76e-08 | 638 | 137 | 15 | 31182584 | |
| Pubmed | 2.24e-07 | 14 | 137 | 4 | 9373155 | ||
| Pubmed | MON2 STX8 FLOT2 ABCC4 DENND4C STT3B VPS13D KIDINS220 DST GPR89A GOLGA2 | 5.45e-06 | 504 | 137 | 11 | 34432599 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 25735837 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 30622227 | ||
| Pubmed | Isolation and characterization of murine Cds (CDP-diacylglycerol synthase) 1 and 2. | 1.54e-05 | 2 | 137 | 2 | 16023307 | |
| Pubmed | Distinct properties of the two isoforms of CDP-diacylglycerol synthase. | 1.54e-05 | 2 | 137 | 2 | 25375833 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 7984047 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 22572823 | ||
| Pubmed | CDP-DAG synthase 1 and 2 regulate lipid droplet growth through distinct mechanisms. | 1.54e-05 | 2 | 137 | 2 | 31548309 | |
| Pubmed | Agrin induces association of Chrna1 mRNA and nicotinic acetylcholine receptor in C2C12 myotubes. | 1.54e-05 | 2 | 137 | 2 | 22884571 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 9618760 | ||
| Pubmed | Isolation and chromosomal localization of two human CDP-diacylglycerol synthase (CDS) genes. | 1.54e-05 | 2 | 137 | 2 | 9806839 | |
| Pubmed | CDP-diacylglycerol synthases regulate the growth of lipid droplets and adipocyte development. | 1.54e-05 | 2 | 137 | 2 | 26946540 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 31968401 | ||
| Pubmed | The Concerted Action of E2-2 and HEB Is Critical for Early Lymphoid Specification. | 1.54e-05 | 2 | 137 | 2 | 30936870 | |
| Pubmed | GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus. | 1.54e-05 | 2 | 137 | 2 | 18794847 | |
| Pubmed | E protein silencing by the leukemogenic AML1-ETO fusion protein. | 2.11e-05 | 14 | 137 | 3 | 15333839 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NWD1 ACACB DOCK11 DOCK9 CCDC57 VPS13D MDN1 SHPRH PUM1 GOLGA2 | 2.95e-05 | 497 | 137 | 10 | 36774506 |
| Pubmed | 3.61e-05 | 407 | 137 | 9 | 12693553 | ||
| Pubmed | 4.18e-05 | 234 | 137 | 7 | 36243803 | ||
| Pubmed | MON2 APH1B TRAPPC11 TCF12 SLC30A8 UBA2 GON4L ARMC2 RNF146 SHARPIN ARHGEF3 SEC14L1 | 4.42e-05 | 750 | 137 | 12 | 11230166 | |
| Pubmed | The helix-loop-helix gene E2A is required for B cell formation. | 4.61e-05 | 3 | 137 | 2 | 8001124 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 30593567 | ||
| Pubmed | Roles of the DOCK-D family proteins in a mouse model of neuroinflammation. | 4.61e-05 | 3 | 137 | 2 | 32241915 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 22659570 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 18854153 | ||
| Pubmed | ALF1, a basic helix-loop-helix transcription factor, maps to mouse chromosome 9. | 4.61e-05 | 3 | 137 | 2 | 8833258 | |
| Pubmed | E2-2 regulates the expansion of pro-B cells and follicular versus marginal zone decisions. | 4.61e-05 | 3 | 137 | 2 | 17082585 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 32220963 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 26671595 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 1321336 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 18384878 | ||
| Pubmed | Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors. | 4.61e-05 | 3 | 137 | 2 | 8643460 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 8261111 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 8649400 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MON2 CCHCR1 TCF12 MYO1E CDS2 TTC27 STT3B MDN1 NUP210 HERC2 FASTKD3 GOLGA2 | 4.65e-05 | 754 | 137 | 12 | 33060197 |
| Pubmed | UBR1 TCF12 GON4L SIN3A DST SBF1 DENND5A PLCH1 PATJ AGRN GOLGA2 | 5.64e-05 | 650 | 137 | 11 | 38777146 | |
| Pubmed | 5.93e-05 | 104 | 137 | 5 | 10470851 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 11802795 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 23897824 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 9407135 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 22433857 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 9824680 | ||
| Pubmed | Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. | 9.19e-05 | 4 | 137 | 2 | 21771727 | |
| Pubmed | Cerebellar Neurodegeneration and Neuronal Circuit Remodeling in Golgi pH Regulator-Deficient Mice. | 9.19e-05 | 4 | 137 | 2 | 31118204 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 16549780 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 7592911 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 25466284 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.01e-04 | 363 | 137 | 8 | 14691545 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 MYO1E DOCK9 MCM5 CELSR1 DST MDN1 SHANK2 SBF1 PKD1 DENND5A HERC2 PUM1 AGRN | 1.24e-04 | 1105 | 137 | 14 | 35748872 |
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 21454521 | ||
| Pubmed | Scrambler, a new neurological mutation of the mouse with abnormalities of neuronal migration. | 1.53e-04 | 5 | 137 | 2 | 8875886 | |
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 21452313 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 7493937 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 2570027 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 17973576 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 11901144 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 15710388 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 8999959 | ||
| Pubmed | 1.58e-04 | 128 | 137 | 5 | 30995482 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FLOT2 DOCK11 DNAH7 DENND4C FSIP2 VPS13D DST MDN1 SBF1 PLCH1 PATJ PUM1 | 1.62e-04 | 861 | 137 | 12 | 36931259 |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 2.14e-04 | 74 | 137 | 4 | 15081110 | |
| Pubmed | Control of developmentally primed erythroid genes by combinatorial co-repressor actions. | 2.25e-04 | 30 | 137 | 3 | 26593974 | |
| Pubmed | XLMR candidate mouse gene, Zcchc12 (Sizn1) is a novel marker of Cajal-Retzius cells. | 2.29e-04 | 6 | 137 | 2 | 21172456 | |
| Pubmed | The RhoGEF DOCK10 is essential for dendritic spine morphogenesis. | 2.29e-04 | 6 | 137 | 2 | 25851601 | |
| Pubmed | Defects in eye development in transgenic mice overexpressing the heparan sulfate proteoglycan agrin. | 2.29e-04 | 6 | 137 | 2 | 17196957 | |
| Pubmed | 2.29e-04 | 6 | 137 | 2 | 9584154 | ||
| Pubmed | 2.29e-04 | 6 | 137 | 2 | 10611232 | ||
| Pubmed | 2.29e-04 | 6 | 137 | 2 | 17878293 | ||
| Pubmed | Differential cooperation between dHAND and three different E-proteins. | 2.29e-04 | 6 | 137 | 2 | 15351717 | |
| Pubmed | 2.48e-04 | 31 | 137 | 3 | 21441570 | ||
| Pubmed | IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5. | 2.53e-04 | 221 | 137 | 6 | 31950832 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.54e-04 | 313 | 137 | 7 | 38270169 | |
| Pubmed | 3.08e-04 | 541 | 137 | 9 | 14983052 | ||
| Pubmed | Rapsyn interaction with calpain stabilizes AChR clusters at the neuromuscular junction. | 3.19e-04 | 7 | 137 | 2 | 17640526 | |
| Pubmed | 3.19e-04 | 7 | 137 | 2 | 8759016 | ||
| Pubmed | 3.19e-04 | 7 | 137 | 2 | 9889000 | ||
| Pubmed | 3.19e-04 | 7 | 137 | 2 | 16015370 | ||
| Pubmed | 3.19e-04 | 7 | 137 | 2 | 25368159 | ||
| Pubmed | ID1 and CEBPA coordinate epidermal progenitor cell differentiation. | 3.19e-04 | 7 | 137 | 2 | 36330928 | |
| Pubmed | 3.19e-04 | 7 | 137 | 2 | 31178125 | ||
| Pubmed | 3.48e-04 | 84 | 137 | 4 | 15123239 | ||
| Pubmed | A probabilistic classifier for olfactory receptor pseudogenes. | 3.57e-04 | 35 | 137 | 3 | 16939646 | |
| Pubmed | 4.06e-04 | 686 | 137 | 10 | 28380382 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 4.17e-04 | 340 | 137 | 7 | 11875048 | |
| Pubmed | 4.17e-04 | 340 | 137 | 7 | 11802173 | ||
| Pubmed | Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. | 4.21e-04 | 37 | 137 | 3 | 20937701 | |
| Pubmed | A kinase-independent role for EGF receptor in autophagy initiation. | 4.25e-04 | 8 | 137 | 2 | 25594178 | |
| Pubmed | TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation. | 4.25e-04 | 8 | 137 | 2 | 32179550 | |
| Pubmed | 4.25e-04 | 8 | 137 | 2 | 18483556 | ||
| Pubmed | The Lyn kinase C-lobe mediates Golgi export of Lyn through conformation-dependent ACSL3 association. | 4.25e-04 | 8 | 137 | 2 | 20605918 | |
| Pubmed | Assignment of a disintegrin and metalloproteinase domain 10 (Adam10) gene to mouse chromosome 9. | 4.25e-04 | 8 | 137 | 2 | 9441766 | |
| Pubmed | Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. | 4.25e-04 | 8 | 137 | 2 | 10655525 | |
| Pubmed | 4.25e-04 | 8 | 137 | 2 | 15944126 | ||
| Pubmed | GSK3 temporally regulates neurogenin 2 proneural activity in the neocortex. | 4.25e-04 | 8 | 137 | 2 | 22674256 | |
| Pubmed | 4.25e-04 | 8 | 137 | 2 | 11784080 | ||
| Pubmed | E protein dosage influences brain development more than family member identity. | 4.25e-04 | 8 | 137 | 2 | 18214987 | |
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 4.31e-04 | 450 | 137 | 8 | 16751776 | |
| Pubmed | 4.39e-04 | 343 | 137 | 7 | 32295537 | ||
| Interaction | GPR182 interactions | MON2 EXOC6 CDS1 MMS22L CDS2 TTC27 STT3B KIDINS220 MDN1 GPR89A ATL2 FASTKD3 SEC14L1 | 5.15e-06 | 455 | 125 | 13 | int:GPR182 |
| Interaction | NR3C1 interactions | GPR89B UBR1 EXOC6 ARMT1 TRAPPC11 FLOT2 ABCA4 ACACB CDS2 DNAH2 MCM5 ATG14 DNAH7 YEATS2 RAB3GAP1 SALL1 MDN1 NUP210 DLAT | 8.82e-06 | 974 | 125 | 19 | int:NR3C1 |
| GeneFamily | Dyneins, axonemal | 1.42e-06 | 17 | 92 | 4 | 536 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 2.70e-04 | 25 | 92 | 3 | 504 | |
| GeneFamily | Exocyst complex | 9.01e-04 | 9 | 92 | 2 | 1055 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP | 7.75e-06 | 200 | 131 | 8 | M6035 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | RELN MID2 GON4L ATG14 AZI2 DENND4C DST PKD1 KCNK1 CCDC68 ZBTB40 ARHGEF3 PUM1 GOLGA2 AP3S2 | 1.60e-05 | 822 | 131 | 15 | M6782 |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-07 | 138 | 137 | 7 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.40e-06 | 179 | 137 | 7 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-06 | 181 | 137 | 7 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 184 | 137 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 184 | 137 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 184 | 137 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-06 | 184 | 137 | 7 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.74e-06 | 185 | 137 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.80e-06 | 186 | 137 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.87e-06 | 187 | 137 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-06 | 190 | 137 | 7 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 190 | 137 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.15e-06 | 191 | 137 | 7 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.15e-06 | 191 | 137 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.23e-06 | 192 | 137 | 7 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.23e-06 | 192 | 137 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.30e-06 | 193 | 137 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.38e-06 | 194 | 137 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.38e-06 | 194 | 137 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.38e-06 | 194 | 137 | 7 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 196 | 137 | 7 | a37ba02446eef5d1fab703204583f6550a8ec3e1 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 2.55e-06 | 196 | 137 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.55e-06 | 196 | 137 | 7 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 196 | 137 | 7 | a156840330630e518bc85633dded6f2c3ead3b30 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 196 | 137 | 7 | 009e83c7251cf300be78b263634d233a8d972a68 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 196 | 137 | 7 | 89ea4d2086e1c769c5a87f1471a6cd4acabcfe33 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.55e-06 | 196 | 137 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 2.64e-06 | 197 | 137 | 7 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-06 | 199 | 137 | 7 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-06 | 199 | 137 | 7 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-06 | 199 | 137 | 7 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-06 | 199 | 137 | 7 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-06 | 199 | 137 | 7 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-06 | 200 | 137 | 7 | e6d36be0c4c569e27303bb4e4f34cd2187e9759d | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Macrophages|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.91e-06 | 200 | 137 | 7 | c0c51719cf81512c50bfcc2fed883c867e522d2a | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-06 | 200 | 137 | 7 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.91e-06 | 200 | 137 | 7 | 758840c31f2ddd7ccf7bf13252ebb48d33e89479 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-06 | 200 | 137 | 7 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.91e-06 | 200 | 137 | 7 | c37fe06a94e5779c56e01389869bb432d3bbaebc | |
| ToppCell | Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type | 1.23e-05 | 165 | 137 | 6 | 8728f927502e56f2768b4224e9111939d3d7815a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-05 | 169 | 137 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-05 | 176 | 137 | 6 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 177 | 137 | 6 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 1.89e-05 | 178 | 137 | 6 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.07e-05 | 181 | 137 | 6 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.14e-05 | 182 | 137 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.14e-05 | 182 | 137 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 182 | 137 | 6 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.20e-05 | 183 | 137 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 183 | 137 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 183 | 137 | 6 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-05 | 184 | 137 | 6 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-05 | 184 | 137 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 2.27e-05 | 184 | 137 | 6 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 2.34e-05 | 185 | 137 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-05 | 185 | 137 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.34e-05 | 185 | 137 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.34e-05 | 185 | 137 | 6 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.34e-05 | 185 | 137 | 6 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.34e-05 | 185 | 137 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.42e-05 | 186 | 137 | 6 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.42e-05 | 186 | 137 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.42e-05 | 186 | 137 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.42e-05 | 186 | 137 | 6 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 186 | 137 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-05 | 186 | 137 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.49e-05 | 187 | 137 | 6 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 187 | 137 | 6 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 2.49e-05 | 187 | 137 | 6 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.49e-05 | 187 | 137 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.49e-05 | 187 | 137 | 6 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 2.57e-05 | 188 | 137 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.57e-05 | 188 | 137 | 6 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-05 | 188 | 137 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 188 | 137 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.57e-05 | 188 | 137 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.57e-05 | 188 | 137 | 6 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.57e-05 | 188 | 137 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 188 | 137 | 6 | 14e120b20e76baa07b6510a94f0c2dcdfdd52357 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 189 | 137 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 189 | 137 | 6 | 443359d90fafae0c1de6bdcce9e8c95df6ea4de8 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 2.64e-05 | 189 | 137 | 6 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.64e-05 | 189 | 137 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.64e-05 | 189 | 137 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.64e-05 | 189 | 137 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 2.72e-05 | 190 | 137 | 6 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.72e-05 | 190 | 137 | 6 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.80e-05 | 191 | 137 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.80e-05 | 191 | 137 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.80e-05 | 191 | 137 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.80e-05 | 191 | 137 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.80e-05 | 191 | 137 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.80e-05 | 191 | 137 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 191 | 137 | 6 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.80e-05 | 191 | 137 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 2.80e-05 | 191 | 137 | 6 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.80e-05 | 191 | 137 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 191 | 137 | 6 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.80e-05 | 191 | 137 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-05 | 192 | 137 | 6 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| Disease | cortical thickness | MON2 STX8 TCF4 FLOT2 RELN ABCA4 DOCK9 GDF10 TENM2 LPAR1 VPS13D CELSR1 CSK ADAMTS9 PKD1 SHARPIN PLCH1 | 1.13e-05 | 1113 | 133 | 17 | EFO_0004840 |
| Disease | gamma-aminobutyric acid receptor-associated protein-like 2 measurement | 6.03e-05 | 3 | 133 | 2 | EFO_0801614 | |
| Disease | Pitt-Hopkins syndrome (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:0060488 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | MON2 EXOC6 STX8 TCF4 PIGL RELN DOCK9 RASGEF1A GDF10 DNAH7 TENM2 LPAR1 CELSR1 ADAMTS9 PKD1 EXOC6B FAM118A | 1.19e-04 | 1345 | 133 | 17 | EFO_0010736 |
| Disease | R-6-hydroxywarfarin measurement | 1.71e-04 | 114 | 133 | 5 | EFO_0803327 | |
| Disease | Intellectual Disability | 2.02e-04 | 447 | 133 | 9 | C3714756 | |
| Disease | ubiquitin-like protein ISG15 measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0021875 | |
| Disease | colorectal cancer | TCF4 ABCC4 UBA2 LPAR1 ADAMTS9 ZBTB40 HERC2 PLCH1 FAM118A PUM1 | 4.26e-04 | 604 | 133 | 10 | MONDO_0005575 |
| Disease | HDL cholesterol change measurement, response to simvastatin, response to fenofibrate | 5.55e-04 | 8 | 133 | 2 | EFO_0007805, GO_1901557, GO_1903491 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 7.11e-04 | 9 | 133 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | carboxypeptidase B measurement | 7.11e-04 | 9 | 133 | 2 | EFO_0801453 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.42e-03 | 49 | 133 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | response to tenofovir | 1.59e-03 | 51 | 133 | 3 | EFO_0009279 | |
| Disease | GDH/6PGL endoplasmic bifunctional protein measurement | 1.77e-03 | 14 | 133 | 2 | EFO_0801619 | |
| Disease | Drug habituation | 1.85e-03 | 115 | 133 | 4 | C0013170 | |
| Disease | Drug abuse | 1.85e-03 | 115 | 133 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.85e-03 | 115 | 133 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.85e-03 | 115 | 133 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.85e-03 | 115 | 133 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.85e-03 | 115 | 133 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.85e-03 | 115 | 133 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.85e-03 | 115 | 133 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.85e-03 | 115 | 133 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.91e-03 | 116 | 133 | 4 | C0740858 | |
| Disease | intraocular pressure measurement | 2.22e-03 | 509 | 133 | 8 | EFO_0004695 | |
| Disease | obesity (implicated_via_orthology) | 2.96e-03 | 215 | 133 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | TCF4 PIGL MMS22L YEATS2 SALL1 RNF146 DNAH17 PKD1 EXOC6B ZBTB40 ABCB11 OR10J4 PATJ | 3.20e-03 | 1206 | 133 | 13 | EFO_0004458 |
| Disease | diabetic retinopathy | 3.40e-03 | 136 | 133 | 4 | EFO_0003770 | |
| Disease | chronic kidney disease (is_marker_for) | 3.63e-03 | 20 | 133 | 2 | DOID:784 (is_marker_for) | |
| Disease | corneal hysteresis | 3.63e-03 | 20 | 133 | 2 | EFO_0010066 | |
| Disease | waist-hip ratio | MMS22L DNAH10 H6PD YEATS2 KIDINS220 CSK ADAMTS9 RNF146 DNAH17 KCNJ15 PKD1 DLAT PATJ | 3.67e-03 | 1226 | 133 | 13 | EFO_0004343 |
| Disease | Profound Mental Retardation | 3.67e-03 | 139 | 133 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 3.67e-03 | 139 | 133 | 4 | C0025363 | |
| Disease | Mental deficiency | 3.67e-03 | 139 | 133 | 4 | C0917816 | |
| Disease | amino acid measurement | 3.70e-03 | 678 | 133 | 9 | EFO_0005134 | |
| Disease | hemoglobin change measurement | 4.39e-03 | 22 | 133 | 2 | EFO_0600027 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LIDQLIRNHEVLSVS | 701 | Q9UKU6 | |
| TRELLVSQHTVQLVG | 461 | Q9UKV3 | |
| SNLHLVTQVQAELLR | 231 | Q9H6S1 | |
| IVLLTHLLVSAQTFI | 191 | Q8WW43 | |
| LETLTDILQHQIRAV | 21 | P18440 | |
| IALCTHLQQLIRTIE | 156 | Q9H993 | |
| EVLVITRAVTHNEQL | 356 | Q9NR81 | |
| LLITVTQSHLVIQNL | 221 | Q92903 | |
| TGTQLVLQHVQALLV | 1346 | P78363 | |
| TQLVNILSHILDVNL | 311 | Q6ZNE5 | |
| EETLHVTNITILVVV | 661 | Q9H2U9 | |
| HLLVQVTATLRNLVD | 446 | Q8NEN0 | |
| NVVLQTLEGHLRSIL | 101 | Q14254 | |
| TIINTLQGVLLFVVH | 421 | Q86SQ3 | |
| QLLTPEHVLRQVDVT | 1801 | O00468 | |
| HVTLLIVVTQSHLVI | 201 | O95674 | |
| EIQQQIVRETFHLVL | 26 | P59780 | |
| IVIAHRLSTIQNADI | 1271 | O95342 | |
| TQLRHSNLVQLLGVI | 241 | P41240 | |
| LVSRATVHILLVDQN | 1081 | Q9NYQ6 | |
| ISILQEQISHLQFVI | 236 | Q9H2F9 | |
| VLVSITVIQIHKQEV | 36 | O75355 | |
| TLLTVQFVHAVVNRI | 1466 | Q149M9 | |
| EIIHQITNVEALIAR | 831 | Q15042 | |
| GNLVIITVVQLNTHL | 41 | Q8NGY2 | |
| IASIIITVIVINTHH | 306 | P02708 | |
| GQRVIQVENSHIILT | 1946 | O00763 | |
| LGLQLHTVLVQEIQE | 66 | Q96T59 | |
| HTVLVQEIQELIEAQ | 71 | Q96T59 | |
| LVVSVIEQLAQVHNS | 46 | P28039 | |
| LALAAHENVVVVTIQ | 156 | Q9UKY3 | |
| AIVDLIHDIQIVSTT | 111 | Q8TEM1 | |
| EVIHSAVQILLSLVG | 146 | Q8N8D7 | |
| LEIAILSRVEHANII | 1051 | Q96RG2 | |
| HLTVNAVLISIASVV | 686 | Q9ULH0 | |
| IQLLQSHISETSVIV | 306 | Q9NSB2 | |
| IILRNLLSCVQEIHS | 4251 | Q9NU22 | |
| VITLHVSALTQTQAV | 536 | P33992 | |
| SLVLVALERHQLIIN | 131 | P50391 | |
| SLQRQILAVHLLQAV | 2066 | O95714 | |
| TVATLDQQVVIHLIS | 1181 | Q6ZRQ5 | |
| DQQVVIHLISTLTQS | 1186 | Q6ZRQ5 | |
| VLLQVETIAQEHSTL | 5141 | Q03001 | |
| ISILVVIIRVSHGIN | 211 | A0A075B734 | |
| ILHQAVAVILSLEQQ | 606 | P15884 | |
| LLFLTAVVQRITVHV | 146 | O00180 | |
| VANLLAIAIERHITV | 136 | Q92633 | |
| DVILISNDIVNIVLH | 2151 | Q5CZC0 | |
| NHATIQSIVRAVGII | 421 | P55107 | |
| LSQLDLIIIHQQVEL | 61 | A0PG75 | |
| TVIRQNHVVDVSVAV | 501 | P10515 | |
| NSVILFVIITQQSLH | 51 | A6NGY5 | |
| LQLLQHITIGTVLQI | 91 | Q8IXQ8 | |
| HQAVAVILSLEQQVR | 621 | Q99081 | |
| HAIFLLVAQLVITTL | 141 | Q99712 | |
| IIAATVENAGIILHI | 206 | Q2M2I5 | |
| IGLTELVQIIINTTH | 551 | Q9Y2D4 | |
| QTVLVLLTTNTVVHD | 126 | Q7Z3U7 | |
| ALREQLQVHIQTIGI | 211 | Q08379 | |
| HIGLTELVQIIINTT | 541 | Q8TAG9 | |
| ELVQIIINTTHLEQA | 546 | Q8TAG9 | |
| DNILIINSAHRQVVL | 346 | P78509 | |
| IQIHKLLQVSVLVVE | 1396 | O95248 | |
| IVAEIRGNVLVLSQH | 1061 | Q14671 | |
| AVVGNITLLHVIRID | 41 | Q8NGF1 | |
| ILHEKITILVTHQLQ | 581 | O15439 | |
| GANLLIIITIQHETV | 46 | Q8NH76 | |
| LEQHIRSPVVLQSIL | 121 | Q9NWS6 | |
| LINIVIVNLIVIHNE | 336 | Q9P2N4 | |
| RIFIHSLDVNVIQQV | 221 | Q96DR5 | |
| FLRTHLQIIIAVSQL | 1521 | Q5JSL3 | |
| HLQVIISVSQLIADV | 1521 | Q9BZ29 | |
| VVQLEELLQVRHSVF | 2111 | Q9UFH2 | |
| QHISFILVGIIIVTS | 341 | B7ZAQ6 | |
| QHISFILVGIIIVTS | 341 | P0CG08 | |
| GTSEIHQIDLIVQLL | 241 | Q15131 | |
| LLLHEQETLTQVTQR | 261 | Q14CM0 | |
| LEVQTYISILQQIIH | 181 | Q12934 | |
| RIHVSLSTVTILQNL | 1021 | P51841 | |
| RQGLVTDQVSLHVLV | 521 | Q96BT3 | |
| QNRVTLGALVVLDVH | 1231 | Q8WXX0 | |
| LTAVNVRNILHEVIT | 286 | Q3T8J9 | |
| VRNILHEVITNEHVV | 291 | Q3T8J9 | |
| QEHIRDLNIVVVSVA | 86 | Q8NHH9 | |
| ILVQLSVHDALILSQ | 366 | Q5VZ89 | |
| IAVIVQLLHNISTAI | 211 | Q8IZF7 | |
| HVEQLQELQTRVLEL | 306 | Q2TAC2 | |
| AELLQVRVQSLTHIL | 291 | Q8TD31 | |
| VRVQSLTHILALQEE | 296 | Q8TD31 | |
| DHTLVNSLIRVLQTL | 1256 | Q6IQ26 | |
| TVIGLFNSVIQIHLL | 151 | Q96DN0 | |
| RDVLQNHLTEVLTLV | 261 | O95479 | |
| VISSQIQTIRNALIH | 1896 | Q8IVF4 | |
| NIEVLSVVAHQILCI | 1861 | Q9P225 | |
| HEILIQIVDASSVIT | 536 | Q92503 | |
| LIEQIRHQILLLASQ | 246 | Q9NSC2 | |
| NHINIIRELASTTQI | 36 | P15086 | |
| VSLRVHTVDDIQQIA | 2651 | P98161 | |
| ILTIFGNLTIILVSH | 36 | Q9GZK3 | |
| HISELILVLISSFNV | 191 | Q8NGF7 | |
| ILCIIHQATQTRELL | 201 | A6NGG8 | |
| ASNAIILIVIRLNHQ | 41 | P0C629 | |
| LVILSGNVTIISVIH | 56 | Q8NGX6 | |
| LTLEVLHLSLVVGQV | 161 | Q96A25 | |
| LVEHLVDIVRSLQNQ | 141 | Q8IUD6 | |
| LLQHIEVNGINLVVT | 131 | Q9Y2B2 | |
| GLASRLQQIQVHVLE | 711 | Q7RTY7 | |
| TSLVTALQALILLHV | 176 | Q14CZ7 | |
| HGLLDRVITNVTIIV | 81 | Q86UD5 | |
| IQSIVRQLQHIVSDE | 1001 | Q96ST3 | |
| VEVLALILTHTRQDV | 381 | Q149N8 | |
| AVLAQHRVALSVQLQ | 196 | Q9H0F6 | |
| AVVAQHSLTQQRLLV | 301 | Q9NTX7 | |
| TVRLNVHKVTVLTLQ | 451 | Q9UBT2 | |
| VILRITENHQVSIIA | 1436 | Q9NT68 | |
| HASINRLVVQVVSSI | 231 | A6NHL2 | |
| NTHEIELIILIFAAI | 191 | Q8NH51 | |
| IAERLQTTVHTLQVI | 871 | Q8N5C6 | |
| TLVIRVVIHDLQQTK | 56 | Q9UPX8 | |
| SIHVNVILFSAILIV | 96 | P58418 | |
| VAANIVLTVVLHQRC | 186 | Q8IWU4 | |
| VVHSEIIITLLSNAV | 426 | Q7Z392 | |
| LVLAQQLTHIELDRV | 216 | Q8N9B8 | |
| THVIEILIVSNSGLI | 196 | P0C645 | |
| EVLRNAGQVVHLTLV | 436 | Q8NI35 | |
| ILNTLNITVHIRDVC | 156 | Q8TCJ2 | |
| LIHAILVRLSVLQQE | 471 | O94964 | |
| VEISRHNVQTLDIIS | 256 | Q06203 | |
| TLARHLIEEQNVISV | 426 | Q8IWV7 | |
| SLVLVALERHQLIIN | 131 | P0DQD5 | |
| LLLRAVSTHQITQLE | 61 | Q9UNK0 | |
| ILQESVISHLIDNVT | 1171 | Q4KWH8 | |
| IHTQLADIIIVAAGI | 256 | Q9H903 | |
| LQSTEHVLGVQLILT | 126 | Q9H6L2 | |
| VFENLIITLQELTHT | 371 | P0CG32 | |
| ILEELIVQGIIQSHS | 111 | H3BQB6 | |
| LERSTVLINQAEHIL | 326 | Q9UJV3 | |
| IVTNNGVIHLIDQVL | 351 | Q15063 | |
| IILVNVRHKLTAIQS | 166 | Q6P3X3 | |
| VIKIDHLETIQQLLT | 1141 | Q9ULM3 | |
| ETILRHNQLILEAIQ | 576 | Q9NUA8 | |
| IDNVILLITGTLHQR | 106 | P61421 | |
| QSIVLLEQHTREVLV | 936 | Q5THJ4 | |
| EQTLVLQIVAGILHL | 271 | Q12965 |